Mr. Mark Rochester

Mr Rochester is the clinical lead for urology at Norfolk & Norwich University Hospital and has a special interest in treatments for Benign prostate enlargement including HOLEP, urolift, rezum, iTind and also aquablation, as well as robotic surgery. He has been involved in a number of clinical trials for new BPH treatments and is currently Chief Investigator for the CLEAR study, as well as actively recruiting to 2 further BPH trials. He is an honorary associate professor at Norwich Medical School and an associate editor for BPH at the Journal of Clinical Urology.